Barclays Maintains Underweight on Aspen Aerogels, Raises Price Target to $5

Benzinga · 3d ago
Barclays analyst David Anderson maintains Aspen Aerogels (NYSE:ASPN) with a Underweight and raises the price target from $4 to $5.